Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases.

Although patients treated with canakinumab showed greater incidence of infections, one positive event was the reported highly significant reduction in incident and fatal lung cancer ( Ridker et al., 2017b ).

also in 132,142 other papers